Does GADOLINIUM Cause Off label use? 95 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Off label use have been filed in association with GADOLINIUM (Gadolinium Metallicum). This represents 7.2% of all adverse event reports for GADOLINIUM.
95
Reports of Off label use with GADOLINIUM
7.2%
of all GADOLINIUM reports
1
Deaths
5
Hospitalizations
How Dangerous Is Off label use From GADOLINIUM?
Of the 95 reports, 1 (1.1%) resulted in death, 5 (5.3%) required hospitalization, and 6 (6.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GADOLINIUM. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does GADOLINIUM Cause?
Nephrogenic systemic fibrosis (370)
Gadolinium deposition disease (310)
Pain (310)
Arthralgia (303)
Fatigue (278)
Burning sensation (272)
Paraesthesia (264)
Hypoaesthesia (260)
Asthenia (257)
Rash (253)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GADOLINIUM Alternatives Have Lower Off label use Risk?
GADOLINIUM vs GADOPENTETATE DIMEGLUMINE
GADOLINIUM vs GADOPICLENOL
GADOLINIUM vs GADOTERATE MEGLUMINE
GADOLINIUM vs GADOTERIDOL
GADOLINIUM vs GADOVERSETAMIDE